Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;1508(1):54-77.
doi: 10.1111/nyas.14701. Epub 2021 Oct 11.

Dietary polyphenol and microbiota interactions in the context of prostate health

Jakub P Piwowarski  1 , Iwona Stanisławska  2 , Sebastian Granica  1
Affiliations
Review

Dietary polyphenol and microbiota interactions in the context of prostate health

Jakub P Piwowarski et al. Ann N Y Acad Sci. 2022 Feb.

Abstract

Recent data strongly indicate a relationship between prostate health and gut microbiota, in which composition and physiological function strictly depend on dietary patterns. The bidirectional interplay of foods containing polyphenols, such as ellagitannins, condensed tannins, lignans, isoflavones, and prenylated flavonoids with human gut microbiota, has been proven to contribute to their impact on prostate health. Considering the attributed role of dietary polyphenols in the prevention of prostate diseases, this paper aims to critically review the studies concerning the influence of polyphenols' postbiotic metabolites on processes associated with the pathophysiology of prostate diseases. Clinical, in vivo, and in vitro studies on polyphenols have been juxtaposed with the current knowledge regarding their pharmacokinetics, microbial metabolism, and potential interactions with microbiota harboring different niches of the human organism. Directions of future research on dietary polyphenols regarding their interaction with microbiota and prostate health have been indicated.

Keywords: microbiota; natural products; polyphenols; postbiotics; prostate.

PubMed Disclaimer

References

    1. Savoca, M.P., A. Inferrera, E.A.M. Verderio, et al. 2019. Search for novel diagnostic biomarkers of prostate inflammation-related disorders: role of transglutaminase isoforms as potential candidates. Mediators Inflamm. 2019: 7894017.
    1. Sung, H., J. Ferlay, R.L. Siegel, et al. 2021. Global cancer statistics 2020: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71: 209-249.
    1. Gronberg, H. 2003. Prostate cancer epidemiology. Lancet 361: 859-864.
    1. Balkwill, F. & A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
    1. zur Hausen, H. 2006. Infections Causing Human Cancer. Willey-VCH.

LinkOut - more resources